Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 24589-98-8 | MDL No. : | MFCD17015455 |
Formula : | C9H8O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OMCTZIDLDSYPOA-UHFFFAOYSA-N |
M.W : | 180.16 | Pubchem ID : | 14395860 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.13 |
TPSA : | 63.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.87 cm/s |
Log Po/w (iLOGP) : | 1.4 |
Log Po/w (XLOGP3) : | 0.75 |
Log Po/w (WLOGP) : | 0.99 |
Log Po/w (MLOGP) : | 0.7 |
Log Po/w (SILICOS-IT) : | 1.39 |
Consensus Log Po/w : | 1.05 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.57 |
Solubility : | 4.82 mg/ml ; 0.0267 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.67 |
Solubility : | 3.9 mg/ml ; 0.0216 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.85 |
Solubility : | 2.57 mg/ml ; 0.0143 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | at 60℃; for 3 h; | Step 1: Synthesis of methyl 4-formyl-3-hydroxybenzoate (239) 4-Formyl-3-hydroxybenzoic acid (1.2 g, 7.22 mmol) was dissolved in MeOH (10 ml). SOCl2 (1.054 ml, 14.45 mmol) was added, and the reaction was stirred at 60° C. for 3 hours to achieve completion. The reaction mixture was concentrated, and the crude was triturated in Hexane and filtered to give methyl 4-formyl-3-hydroxybenzoate (1.3 g, 7.22 mmol, 100percent yield). MS/ESI+ 181.04 [MH]+ |
85% | Reflux | 4-Formyl-3-hydroxybenzoic acid (5 g, 30 mmol) was suspended in methanol (70 mL), and treated with thionyl chloride (3.29 mL 45 mmol) dropwise. The mixture was heated to reflux overnight. Concentrated to dryness, and 50 mL of toluene was added, and concentrated again. The residue was recrystallized from ethyl acetate-hexane. A total of 4.8 g (85percent) of methyl 4-formyl-3-hydroxybenzoate was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37% | With sodium tetrahydroborate; palladium 10% on activated carbon; oxygen; potassium carbonate In methanol; water | To a solution of 250 mg (1.37mmol) methyl3-hydroxy-4-(hydroxymethyl)benzoate in 3 mL 10percent aqueous methanol was added 73 mg (10percentloading, 0. 034 mmol, 2. 5 molpercent) Pd/C, 567 mg ( 4.11 mmol, 3 eq) potassium carbonate,and 5.2 mg (0.137, 0.1 eq) sodium borohydride, and the mixture was stirred under anatmosphere of oxygen overnight. Then, the mixture was diluted with dichloromethaneand filtered. The mixture was concentrated in vacuo, partitioned between ethyl acetateand water, and the aqueous layer extracted two more times with ethyl acetate. The combined organic phases were then dried over sodium sulfate. The solvent was removedunder reduced pressure and the product was purified by column chromatography. 92 mg(0.506 mmol, 37percent) of the methyl4-formyl-3-hydroxybenzoate were obtained as a whitesolid. Rf(25percent EtOAc, 75percent Hexanes) = 0.50; 1H NMR (600 MHz, Chloroform-d) 8 10.94(s, 1H), 9.98 (s, 1H), 7.69-7.63 (m, 3H), 3.94 (s, 3H). 13C NMR (126 MHz, Chloroform-d) 8196.44, 165.67, 161.24, 137.30, 133.62, 122.86, 120.40, 119.12, 52.69. HRMS: m/z(+H+). calc'd: 181.0495, found: 181.0494. |
[ 4670-56-8 ]
Methyl 2-hydroxy-4-methylbenzoate
Similarity: 0.98
[ 6342-72-9 ]
Dimethyl 2-hydroxyterephthalate
Similarity: 0.98
[ 808123-00-4 ]
3-Hydroxy-4-(methoxycarbonyl)benzoic acid
Similarity: 0.98
[ 29602-00-4 ]
2-Hydroxy-4-(methoxycarbonyl)benzoic acid
Similarity: 0.98
[ 42137-51-9 ]
Methyl 4-formyl-2-hydroxybenzoate
Similarity: 0.98
[ 24589-99-9 ]
Methyl 3-formyl-4-hydroxybenzoate
Similarity: 0.97
[ 328030-95-1 ]
Methyl 3,5-diformyl-4-hydroxybenzoate
Similarity: 0.97
[ 41489-76-3 ]
Methyl 5-formyl-2-hydroxybenzoate
Similarity: 0.95
[ 74733-24-7 ]
Methyl 4-formyl-3-methoxybenzoate
Similarity: 0.93
[ 4670-56-8 ]
Methyl 2-hydroxy-4-methylbenzoate
Similarity: 0.98
[ 6342-72-9 ]
Dimethyl 2-hydroxyterephthalate
Similarity: 0.98
[ 808123-00-4 ]
3-Hydroxy-4-(methoxycarbonyl)benzoic acid
Similarity: 0.98
[ 29602-00-4 ]
2-Hydroxy-4-(methoxycarbonyl)benzoic acid
Similarity: 0.98